Felicia Vonella | Executive Director-Investor Relations |
Ron Cohen | Chief Executive Officer |
Cory Kasimov | JP Morgan |
Ben Burnett | Stifel |
Paul Matteis | Stifel |
Sadia Rahman | Cantor Fitzgerald |
Phil Nadeau | Cowen and Company |
Michael Yee | Jefferies |
Salveen Richter | Goldman Sachs |
Silvan Tuerkcan | Oppenheimer |
Edward Marks | HC Wainwright |
Welcome to the Acorda Therapeutics Fourth Quarter Year-End 2018 Update. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request. I will now introduce your host for today’s call, Felicia Vonella, Executive Director of Investor Relations at Acorda.